Ford Brian D. 4
4 · Acasti Pharma Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Ford Brian D.
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Options (Right to Buy)
2022-06-22+165,000→ 165,000 totalExercise: $0.89Exp: 2032-06-22→ Class A Common Shares (165,000 underlying)
Footnotes (2)
- [F1]Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant.
- [F2]Stock options granted on 06/22/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.